,,iii  #aai? ,,congress  #b;d ,session  
,s4 ,,res4 #ijg  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,septemb] #bd1        
#bjbf,ms4 ,slotk9 7= h]self & ,mrs4     
,britt7 submitt$ ! foll[+ resolution2   
:i* 0 ref]r$ to ! ,committee on ,heal?1 
,education1 ,labor1 & ,p5sions          
,,resolution  ,support+ ! designation ( 
,septemb] #bjbf z ,national ,ov>ian     
,canc] ,aw>5ess ,mon?4  ,:]eas ov>ian   
canc] is ! fif?-lead+ cause ( canc]     
dea?s ( wom5 9 ! ,unit$ ,/ates & causes 
m dea?s ?an any o!r gynecologic canc]2  
,:]eas1 9 ! ,unit$ ,/ates1 a woman's    
lifetime risk ( be+ diagnos$ ) ov>ian   
canc] is ab\t #a 9 #ia2 ,:]eas !        
,am]ican ,canc] ,society e/imates       
#bj1jaj cases ( ov>ian canc] w be newly 
diagnos$ 9 #bjbf1 & #ab1dej individuals 
w die f ! disease nationwide2 ,:]eas !  
#e-ye> survival rate = ov>ian canc] is  
#ea4f p]c5t1 & survival rates v>y       
greatly dep5d+ on ! /age ( diagnosis2   
,:]eas ! #e-ye> survival rate = ov>ian  
canc] exce$s #ij p]c5t = individuals    

diagnos$ 9 e>ly /ages2 ,:]eas1 :ile !   
mammogram c detect brea/ canc] & ! ,pap 
sme> c detect c]vical canc]1 !re is no  
reliable e>ly detection te/ = ov>ian    
canc]2 ,:]eas1 9 ,june #bjjg1 ! fir/    
national cons5sus /atem5t on ov>ian     
canc] symptoms 0 e/abli%$ to provide    
consi/5cy 9 recogniz+ symptoms1 mak+ !m 
easi] to id5tify & report2 ,:]eas ,black
 wom5 ) ov>ian canc] are m likely to    
receive late-/age diagnoses1 exp]i5ce   
delay$ or l[] quality cl9ical c>e1 &    
face l[] #e-ye> survival rates comp>$ to
 non-,black wom52 ,:]eas disp>ities 9   
c>e p]si/1 ) ,black wom5 exp]i5c+ l[]   
survival rates ?an ,:ite wom52 ,:]eas   
wom5 ( color1 l[-income wom51 & wom5    
liv+ 9 rural areas face sy/emic b>ri]s  
to high-quality c>e & are less likely to
 receive treatm5t adh]+ to ,national    
,compreh5sive ,canc] ,network 7ref]r$ to
 9 ?is preamble z ! ,,nccn7 treatm5t    
guidel9es2 ,:]eas ! proportion ( ov>ian 
canc] cases 9 wom5 s]v+ on active duty 9
 ! ,arm$ ,=ces :o are less ?an #de ye>s 

( age is sub/antially great] ?an 9 !    
g5]al population2 ,:]eas ! symptoms (   
ov>ian canc]1 :i* include bloat+1 pelvic
 or abdom9al pa91 difficulty eat+ or    
feel+ full quickly1 ur9>y symptoms1 &   
sev]al o!r symptoms1 are (t5 vague & are
 (t5 easily misattribut$ to o!r         
diseases2 ,:]eas improv$ public &       
cl9ical aw>5ess ( ov>ian canc] symptoms 
c lead to e>li] pres5tation1 fa/]       
diagno/ic evaluation1 & exp&$ treatm5t  
options2 ,:]eas ! abs5ce ( an e>ly      
detection te/ = ov>ian canc] comb9$ )   
its vague symptoms mean t approximately 
#hj p]c5t ( cases ( ov>ian canc] are    
detect$ at an advanc$ /age2 ,:]eas gaps 
9 collect+ & report+ data on treatm5t & 
outcomes relat$ to ov>ian canc] risk1   
especially = und]s]v$ communities &     
m>g9aliz$ populations1 c imp$e !        
developm5t ( effective heal? policies2  
,:]eas all wom5 are at risk = ov>ian    
canc]1 b approximately #bj p]c5t ( wom5 
:o are diagnos$ ) ov>ian canc] h a      
h]$it>y pr$isposition to ov>ian canc]1  

:i* places !m at ev5 high] risk2 ,:]eas 
sci5ti/s & physicians h uncov]$ *anges 9
 ! ,,brca g5es t "s wom5 inh]it f _!    
p>5ts1 :i* may make ^? wom5 #cj times m 
likely to develop ov>ian canc]2 ,:]eas !
 family hi/ory ( a woman has be5 f\nd to
 play an important role 9 accurately    
assess+ h] risk ( develop+ ov>ian canc]1
 & m$ical exp]ts believe t family hi/ory
 %\ld be tak5 into consid]ation dur+ !  
annual well-woman visit ( any woman2    
,:]eas ^? wom5 :o h a family hi/ory (   
ov>ian or brea/ canc] %\ld consid]      
g5etic te/+ & c\nsel+ to det]m9e :e!r _!
 risk ( develop+ a h]itable canc] is    
elevat$2 ,:]eas wom5 :o "k t !y are at  
high risk ( ov>ian canc] may und]take   
prophylactic measures l a               
salp+o-oophorectomy to help r$uce ! risk
 ( develop+ ?is disease2 ,:]eas         
guidel9es issu$ by ! ,,nccn & ! ,society
 ( ,gynecologic ,oncology recomm5d t all
 individuals diagnos$ ) ov>ian canc]    
receive g5etic c\nsel+ & g5etic te/+    
reg>dless ( _! family hi/ory2 ,:]eas    

/udies cont9ue to %[ t _m individuals   
diagnos$ ) ov>ian canc] d n receive     
recomm5d$ g5etic c\nsel+ & te/+2 ,:]eas1
 accord+ to a cons5sus report by !      
,national ,academy ( ,m$ic9e1 !re rema9 
surpris+ gaps 9 ! fundam5tal k ab\t &   
und]/&+ ( ov>ian canc] across all       
aspects ( ! disease2 ,:]eas advances 9  
precision m$ic9e1 g5etic te/+1 t>get$   
!rapies1 & ma9t5ance treatm5ts h improv$
 outcomes = _m pati5ts ) ov>ian canc]1  
yet significant unmet ne$s rema91       
p>ticul>ly 9 e>ly detection2 ,:]eas     
ov>ian canc] rese>* rema9s und]fund$    
relative to its mortality rate1 mak+    
increas$ ,f$]al inve/m5t critical to    
progress2 ,:]eas ongo+ inve/m5ts 9      
ov>ian canc] rese>* & education &       
aw>5ess ef=ts are critical to clos+ ^!  
gaps & improv+ survivor%ip = wom5 )     
ov>ian canc]2 ,:]eas1 ea* ye> dur+ !    
mon? ( ,septemb]1 ! ,ov>ian ,canc]      
,rese>* ,alliance & community p>tn]     
organizations hold a numb] ( ev5ts to   
increase public aw>5ess ( ov>ian canc] &

 its symptoms2 & ,:]eas ,septemb] #bjbf 
%\ld be designat$ z ,national ,ov>ian   
,canc] ,aw>5ess ,mon? to increase public
 aw>5ess ( ov>ian canc]3 ,n[1 !re=e1 be 
x ,t ! ,s5ate-- 7#a7 supports !         
designation ( ,national ,ov>ian ,canc]  
,aw>5ess ,mon?2 &  7#b7 supports ! goals
 & ideals ( ,national ,ov>ian ,canc]    
,aw>5ess ,mon?4